These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7014121)

  • 1. Adverse effect of propranolol on airway function in nonasthmatic chronic obstructive lung disease.
    Chester EH; Schwartz HJ; Fleming GM
    Chest; 1981 May; 79(5):540-4. PubMed ID: 7014121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-adrenergic blockade of the lung. Dose-dependent cardioselectivity of tolamolol in asthma.
    Fleming GM; Chester EH; Schwartz HJ; Jones PK
    Chest; 1978 Jun; 73(6):807-12. PubMed ID: 350512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Propranolol and pindolol in chronic obstructive lung disease (author's transl)].
    Ulmer WT; Lanser K
    Dtsch Med Wochenschr; 1976 Nov; 101(48):1765-8. PubMed ID: 791605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detrimental effects of beta-blockers in COPD: a concern for nonselective beta-blockers.
    van der Woude HJ; Zaagsma J; Postma DS; Winter TH; van Hulst M; Aalbers R
    Chest; 2005 Mar; 127(3):818-24. PubMed ID: 15764762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-adrenoceptor blockers and terbutaline in patients with chronic obstructive lung disease. Effects and interaction after oral administration.
    Wunderlich J; Macha HN; Wudicke H; Huckauf H
    Chest; 1980 Nov; 78(5):714-20. PubMed ID: 6107217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of a new cardioselective beta-adrenergic blocker (atenolol) on airway resistance in chronic obstructive disease (author's transl)].
    Beil M; Ulmer WT
    Arzneimittelforschung; 1977 Feb; 27(2):419-22. PubMed ID: 324487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The usefulness of theophylline in nonasthmatic airway obstruction.
    Schmidt R; Altschuler S
    Angiology; 1979 Nov; 30(11):744-9. PubMed ID: 389103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute respiratory and cardiovascular effects of inhaled ketanserin in chronic obstructive pulmonary disease. A comparative study with intravenously administered ketanserin.
    Cazzola M; Guidetti E; Sepe J; Assogna G; Lucchetti G; Santangelo G; D'Amato G
    Chest; 1990 Apr; 97(4):901-5. PubMed ID: 2182300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects on airway conductance of a new selective beta-adrenergic blocking drug, atenolol, and propranolol in asthmatic subjects.
    Aström H
    Scand J Respir Dis; 1975; 56(6):292-6. PubMed ID: 1221496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-adrenergic function in airways of healthy and asthmatic subjects.
    Gayrard P; Orehek J; Grimaud C; Charpin J
    Thorax; 1975 Dec; 30(6):657-62. PubMed ID: 769241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the influence of the beta-blocker metoprolol on flow resistance of airways in patients with chronic obstructive disease of airways (author's transl)].
    Ulmer WT; Zimmerman I
    Arzneimittelforschung; 1980; 30(4):686-8. PubMed ID: 6994752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-adrenergic blockade in ponies with recurrent obstructive pulmonary disease.
    Scott JS; Broadstone RV; Derksen FJ; Robinson NE
    J Appl Physiol (1985); 1988 Jun; 64(6):2324-8. PubMed ID: 2841272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta blockers and COPD.
    Jenne JW
    Chest; 1980 Nov; 78(5):675-6. PubMed ID: 6107216
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of muliple doses of metoprolol and propranolol on ventilatory function in patients with chronic obstructive lung disease.
    Tivenius L
    Scand J Respir Dis; 1976; 57(4):190-6. PubMed ID: 790561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A technical inhalation test variant for improving the effectiveness of the use of dose aerosols].
    Gregori P
    Z Erkr Atmungsorgane; 1990; 174(3):190-5. PubMed ID: 1975966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of propranolol on respiratory function and exercise tolerance in patients with chronic obstructive lung disease.
    Nordstrom LA; MacDonald F; Gobel FL
    Chest; 1975 Mar; 67(3):287-92. PubMed ID: 1112122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 30 mg of morphine alone or with promethazine or prochlorperazine on the exercise capacity of patients with COPD.
    Light RW; Stansbury DW; Webster JS
    Chest; 1996 Apr; 109(4):975-81. PubMed ID: 8635380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhalation challenge with carbachol and isoproterenol to predict bronchospastic response to propranolol in COPD.
    Popio KA; Jackson DH; Utell MJ; Swinburne AJ; Hyde RW
    Chest; 1983 Feb; 83(2):175-9. PubMed ID: 6822096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a dual effect by beta-adrenoceptor antagonists on post-exercise airway calibre.
    Berkin KE; Walker G; Thomson NC
    Eur Respir J; 1988 Mar; 1(3):227-31. PubMed ID: 2838318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation into isoprenaline resistance in patients with obstructive lung disease.
    Lichterfeld A; Löllgen H
    Eur J Clin Pharmacol; 1974 Aug; 7(5):347-51. PubMed ID: 4609138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.